Medicine and Dentistry
Patient
100%
Neoplasm
96%
Surgery
76%
Analysis
59%
Oxygen
45%
Metabolism
45%
Glioblastoma
45%
Ganglioglioma
43%
Mycosis fungoides
43%
Meningioma
43%
Melanoma Cell
43%
Survival
43%
Diagnosis
40%
Phenotype
32%
Magnetic Resonance Imaging
32%
Soft Tissue
29%
Cutaneous T Cell Lymphoma
27%
Lymphoma
27%
Therapeutic Procedure
25%
Kidney Transplantation
24%
Nodular Melanoma
23%
Tumor Microenvironment
23%
Chondroitin Sulfate
21%
Recurrent Disease
21%
Adenocarcinoma
21%
Myoepithelial Carcinoma
21%
Peripheral T-Cell Lymphoma
21%
Complication
21%
Mast Cell
21%
Breast Implant
21%
Right Ventricle
21%
Ampulla of Vater
21%
Cutaneous Lymphoma
21%
Isocitrate Dehydrogenase
21%
Parotid Gland
21%
Molecular Diagnosis
21%
Life
21%
Soft Tissue Tumor
21%
Adult T-Cell Leukemia/Lymphoma
21%
Implant
21%
Gram-Positive Bacteria
21%
Dermatology
21%
Patient Referral
21%
Bone Tissue
21%
Drive
21%
Immunotherapy
21%
Gene Mutation
21%
Hypoxemia
21%
Promoter Region
21%
Notch Signaling
21%
Biochemistry, Genetics and Molecular Biology
Phenotype
49%
Survival
33%
Promoter Region
32%
Magnetic Resonance Imaging
26%
DNA Methylation
24%
Chondroitin Sulfate
21%
Methylation
21%
Neovascularization (Pathology)
21%
Wild Type
21%
Metabolic Pathway
21%
IDH1
21%
Nested Gene
21%
Time
21%
Immune Response
21%
Notch Signaling Pathway
21%
Tenascin C
21%
Animal Models
21%
Genetic Code
21%
Sample
20%
Electric Potential
19%
Association
15%
Epigenetics
14%
Mesenchymal-Epithelial Transition
13%
Pig
13%
Digital Pathology
11%
Vimentin
10%
Genetic Transcription
10%
MMP2
10%
Electrophoretic Mobility Shift Assay
10%
Transcription Factor
10%
down Regulation
10%
Luciferase
10%
Growth
10%
Morphology
10%
Sheep
10%
WT1
9%
Genetics
8%
Isocitrate Dehydrogenase
8%
Oxidative Phosphorylation
8%
Glycolysis
8%
Progression Free Survival
8%
Classification
8%
Contrast Enhancement
7%
Incidence
7%
Overall Survival
7%
MEK Inhibitor
6%
Toll-Like Receptor
5%